Jeffrey M. Fowler, MD (Ob/Gyn)

Jeffrey M. Fowler, MD

I am a professor of gynecologic oncology at The Ohio State University and have been in practice since 1991. I have extensive expertise in the latest surgical techniques, including radical pelvic surgery, pelvic reconstruction and minimally invasive surgery including laparoscopic and robotic surgery, and have taught these techniques to other surgeons locally, nationally and internationally. I am also the medical director for the Robotic Surgery Program at The Ohio State University Medical Center. I was named to the Castle Connolly list of “America’s Top Doctors” from 2008-2019 and rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016 and 2017. I have served as chief of staff for the James Cancer Hospital and currently serve as vice-chair of the Department of Obstetrics and Gynecology. I grew up in Michigan and attended Kalamazoo College and then graduated from Northwestern University Medical School in Chicago. I completed my residency at The Ohio State University College of Medicine and pursued a fellowship in gynecologic oncology at the UCLA School of Medicine and Cedars-Sinai in Los Angeles. After fellowship, I joined the faculty of the University of Minnesota Hospital and Clinic as an assistant professor. In 1997, I returned to The Ohio State University College of Medicine as an associate professor of obstetrics and gynecology and served as director of the Division of Gynecologic Oncology through 2010. In 2001, I was named the inaugural holder of the John G. Boutselis Chair in Gynecologic Oncology, and in 2002 was promoted to full professor. I have represented The Ohio State University in many leadership roles. I serve as a board examiner for general obstetrics and gynecology and gynecologic oncology subspecialty oral exams for the American Board of Obstetrics and Gynecology (ABOG) and completed a six-year term as board member for ABOG’s Division of Gynecologic Oncology. I served on the Board of Governors of the American College of Surgeons and most recently as the president of the Society of Gynecologic Oncology. As a member of the Cancer Control Program at the OSUCCC – James, my research is focused on advancing state-of-the-art surgery in gynecologic oncology, including minimally invasive surgery (laparoscopy and robotics), radical pelvic surgery and pelvic reconstructive surgery. I also teach these techniques to surgeons from around the world. One of my clinical research projects revealed that fluid accumulation in the peritoneal cavity of patients with advanced ovarian cancer is a prognostic of poor overall survival. These ascites may predict a group of women who are more likely to see long-term benefit from the drug bevacizumab. I have authored or co-authored more than 180 articles in such well-respected publications as Journal of Minimally Invasive Gynecology, Gynecologic Oncology, American Journal of Obstetrics & Gynecology and International Journal of Gynecological Cancer. I have also written numerous book chapters and abstracts presented at scholarly meetings, and currently serve on the editorial boards for the journals Gynecologic Oncology and Journal of Robotic Surgery.

Previous ArticleNext Article